PEYTON COUPER: Open Payments
NPI 1285411363 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,181 in 57 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $617 · 2025 $1,181
Food & beverage: $1,181
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $229 |
| Daiichi Sankyo Inc. | 10 | $200 |
| ABBVIE INC. | 6 | $152 |
| Novartis Pharmaceuticals Corporation | 7 | $135 |
| PFIZER INC. | 4 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| TerSera Therapeutics LLC | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: Enhertu, KISQALI, IBRANCE, VENCLEXTA, ERLEADA, DARZALEX, RYBREVANT, EPKINLY.
Industry payments across GA — which companies pay providers there.
